For research and educational purposes only. Not medical advice.

LGD-3303 Reference

Educational, not medical advice reference for LGD-3303: SARM; regulatory status, evidence posture, source review, and schedule notes. Also known as Non-stero…

Reference summary

Preclinical osteoporosis-model work exists; no completed human clinical program.

Categories

SARM

Aliases

Non-steroidal SARM, Ligand Pharmaceuticals investigational

Evidence posture

preclinical — FDA enforcement attention. Sold only as a research chemical, not for human consumption per legal seller terms. WADA-prohibited under category S1.2 at all times. No completed human clinical program; LGD-3303 was not advanced past early-phase development by the original sponsor.

Regulatory status

No FDA-approved LGD-3303 drug label. WADA prohibits SARMs under category S1.2 at all times. FDA enforcement against SARMs sellers applies. LGD-3303 was an earlier Ligand Pharmaceuticals SARM that did not advance to a Phase 3 program.

Content review status

research reference

Selected public sources

• FDA consumer update: SARMs are not FDA-approved and cannot be legally marketed as dietary supplements
• WADA prohibited list: SARMs are category S1.2 anabolic agents prohibited at all times
• PubMed search: LGD-3303 SARM literature